Literature DB >> 11737687

Acute juvenile pityriasis rubra pilaris: a superantigen mediated disease?

I Betlloch1, R Ramón, J F Silvestre, L Carnero, M P Albares, J Bañuls.   

Abstract

Juvenile acute pityriasis rubra pilaris (JAPRP) is a form of pityriasis rubra pilaris (PRP) with particular clinical characteristics and course. It is usually preceded by an infectious condition. We report a boy, initially thought to have Kawasaki disease, and subsequently diagnosed as having JAPRP, who made a satisfactory recovery. In this case, prior antibiotic treatment made it impossible to show the presence of any microorganism. However, the clinical characteristics of these patients and the similarities with other disorders involving the skin that are mediated by superantigens led us to think that these antigens may be involved in the development of this disease. Also, in view of the obvious differences between JAPRP and the other PRP, we suggest that, in the future this disorder may be considered a separate entity as a reactive exanthem.

Entities:  

Mesh:

Year:  2001        PMID: 11737687     DOI: 10.1046/j.1525-1470.2001.01967.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  4 in total

1.  An unusual rash.

Authors:  Dominic Muogbo; David Cremonesini
Journal:  BMJ Case Rep       Date:  2010-05-19

2.  Familial pityriasis rubra pilaris is caused by mutations in CARD14.

Authors:  Dana Fuchs-Telem; Ofer Sarig; Maurice A M van Steensel; Ofer Isakov; Shirli Israeli; Janna Nousbeck; Katharina Richard; Veronique Winnepenninckx; Marigje Vernooij; Noam Shomron; Jouni Uitto; Philip Fleckman; Gabriele Richard; Eli Sprecher
Journal:  Am J Hum Genet       Date:  2012-06-14       Impact factor: 11.025

3.  [Pityriasis rubra pilaris. Case reports and review of the literature].

Authors:  S Artik; M Megahed; T Ruzicka
Journal:  Hautarzt       Date:  2003-06-25       Impact factor: 0.751

4.  Acute postinfectious pityriasis rubra pilaris as a cutaneous manifestation in COVID-19: a case report and its dermoscopic features.

Authors:  D Kadylak; W Barańska-Rybak
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-06-11       Impact factor: 9.228

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.